News, reviews and podcasts from annual scientific meetings and symposiums around the world.
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant…
Using an investigational oral form of azacitidine therapy, CC-486, significantly improved overall survival in older…
Researchers have completed the first comprehensive analysis combining full genomic sequencing and gene expression profiles…
Adding daratumumab to carfilzomib and dexamethasone to treat patients with relapsed or refractory multiple myeloma…
The immunotherapy drug blinatumomab significantly improved survival in children with relapsed B-acute lymphoblastic leukaemia (B-ALL)…
The phase 3 ALCYONE study showed the addition of daratumumab to bortezomib, melphalan and prednisone (D-VMP) improved…
Promising pre-clinical results using a bispecific T-cell engager (BiTE), an experimental immunotherapy agent to attack…
A new analysis shows that a donor stem cell transplant following treatment with an immune…
The use of high-dose-rate brachytherapy to treat elderly patients with common skin cancers offers excellent…
A novel MRI-guided procedure that uses therapeutic ultrasound effectively treats prostate cancer with minimal side…